ALLEGAN, Mich. — Perrigo Co. has received final approval from the Food and Drug Administration for cetirizine hydrochloride oral solution (1 mg/ml), bubble gum-flavored.
The company said Tuesday that its allergy product is the store-brand equivalent of McNeil-PPC Inc.’s Children’s Zyrtec Allergy Syrup (1 mg/ml, bubble gum-flavored).
Perrigo said it expects to begin shipping its product during the upcoming cough/cold/flu season.
Children’s Zyrtec Allergy Syrup, indicated for relief from symptoms of indoor and outdoor allergies in children ages 2 and older, is part of the overall Zyrtec brand, with estimated annual sales of about $380 million, Perrigo reported.
"This approval strengthens our leading store-brand position and highlights our commitment to bringing new products to the market," stated Perrigo chairman and chief executive officer Joseph Papa.
